Financial navigation for Malignancies

Phase-Based Progress Estimates
Kaiser Permanente Washington Health Research Institute, Seattle, WA
Financial navigation - Behavioral
All Sexes
Eligible conditions

Study Summary

This study is evaluating whether a financial navigation intervention can help people with cancer.

See full description

Treatment Effectiveness

Effectiveness Estimate

1 of 3

Study Objectives

This trial is evaluating whether Financial navigation will improve 2 primary outcomes, 1 secondary outcome, and 6 other outcomes in patients with Malignancies. Measurement will happen over the course of between baseline and 12 months.

baseline and 12 months
Financial distress
Financial hardship due to cancer care costs
Health-related quality of life (cancer specific)
Month 12
Delinquent account
Initiation of cancer treatment
Out of pocket (OOP) expenditures
Patient Assessment of cancer Communication Experiences (PACE)
Time to initiation of cancer treatment
Use of medical financial assistance (MFA)

Trial Safety

Safety Estimate

1 of 3

Trial Design

3 Treatment Groups

Arm 1: Enhanced usual care
1 of 3
Arm 2: Brief financial navigation intervention
1 of 3
Arm 3: Extended financial navigation intervention
1 of 3
Active Control
Experimental Treatment

This trial requires 370 total participants across 3 different treatment groups

This trial involves 3 different treatments. Financial Navigation is the primary treatment being studied. Participants will be divided into 2 treatment groups. There is no placebo group. The treatments being tested are not being studied for commercial purposes.

Arm 2: Brief financial navigation intervention
Participants in this arm will receive their usual care, and the Financial Resource Sheet described in Arm 1, plus one (1) cycle of financial navigation (total cycles: 1; total length: 6 months). In each intervention cycle participants will get at least one (1) phone call with a CAFÉ Financial Navigator, the navigator will talk with participants to identify financial questions or concerns. The navigator will create a personalized plan for each participant. Participants can request extra support from the navigator for up to 6 months.
Arm 3: Extended financial navigation intervention
Participants in this arm will receive their usual care, a Financial Resource Sheet and the brief intervention described in Arm 2 (i.e., one (1) cycle of financial navigation). Plus, they will receive two (2) additional cycles of financial navigation (total cycles: 3; total length: 6 months).
Arm 1: Enhanced usual care
Participants in this arm will receive their usual care plus a Financial Resource Sheet. The financial resource sheet lists and describes existing organization and community resources available to KP members.

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline and 12 months
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly baseline and 12 months for reporting.

Closest Location

Kaiser Permanente Washington Health Research Institute - Seattle, WA

Eligibility Criteria

This trial is for patients born any sex aged 18 and older. There are 6 eligibility criteria to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
A person must be at least 18 years old to be carded. show original
I had a recent visit to the CAFÉ clinic/department show original
The current, living member as of the identification date is the person who is identified on the identification date. show original
To be eligible for the Illinois ID card, you must be a resident of Illinois, continuously enrolled at a school or college in Illinois for at least six months prior to your identification date, and at least 16 years old. show original
KPNW and KPWA members who have been recently diagnosed with cancer are eligible for a free 120-day membership. show original
We are looking for an English speaker for KPWA show original

Patient Q&A Section

How serious can malignancies be?

"The probability of survival was lower for women with malignancies, and the prognosis was worse for men and women with malignancies. Malignancies are associated with high comorbidity and have worse prognoses. The prognosis in patients with malignancies is worse." - Anonymous Online Contributor

Unverified Answer

What are the signs of malignancies?

"In common with many other diseases, the cause of malignancies is not always apparent. The signs that occur may lead to a suspicion of a malignancy and thus prompt referral for a full investigation (imaging, biological analysis). In the meantime, treatment should be continued under full observation." - Anonymous Online Contributor

Unverified Answer

What are common treatments for malignancies?

"While chemotherapy is one of the most effective means for eliminating tumors and prolonging survival, there are many tumor types where chemotherapy is ineffective or does not prolong survival. Because of these discrepancies, tumor types with aggressive and recurrent forms need to be carefully monitored and promptly treated." - Anonymous Online Contributor

Unverified Answer

How many people get malignancies a year in the United States?

"Nearly 1.6 million US people in 2010 were diagnosed with a malignant neoplasm. It makes up 7.6% of all cancers. The most common forms were breast, colon, pancreas, and lung." - Anonymous Online Contributor

Unverified Answer

What causes malignancies?

"Most of the cancers can be described as genetic diseases caused by genetic changes. Cancer is the result of disruption of normal genomic processes, which occur at every level of the organism; so even a non-cellular entity like DNA has the potential to cause cancer. In addition cancer cells and their microenvironment, as in cancer metastasis, can further change the normal genome and cause the disease. So in addition to specific genetic changes tumor cells undergo a major epigenetic change via a number of pathways. For example in cancer cells transcription factors like p53 and p63 are frequently mutated or deregulated, making them less able to exert their normal functions and thus causing cell cycle arrest or apoptosis." - Anonymous Online Contributor

Unverified Answer

What is malignancies?

"For the first time to date, the US has reported on both breast, prostate and gynecologic cancers. The incidence of breast, prostate and gynecological cancers continue to increase in recent decades." - Anonymous Online Contributor

Unverified Answer

Can malignancies be cured?

"In a wide variety of malignancies, most patients do not recover from the disease with only standard surgery and/or chemotherapy. However, certain malignancies can respond to treatment and some patients respond to treatment with no recovery (i.e., cancer). Thus, there is no guarantee that malignancies will never recur after treatment." - Anonymous Online Contributor

Unverified Answer

What is financial navigation?

"financial navigation is a complex subject that usually depends on individual financial and credit histories. Results from a recent paper and experience with financial navigation highlight the challenges encountered by individuals searching for financial plans. Therefore, it is essential to promote [financial navigation] as an alternative method of finding insurance plans and assisting clients over the transition between life and health insurance." - Anonymous Online Contributor

Unverified Answer

What is the primary cause of malignancies?

"The study of malignancy is essential for the understanding of the malignant process and consequently of therapeutic interventions. Even though the epidemiology of malignancy remains relatively simple, and its primary causes are easily determined, the pathophysiological pathway from the primary cause to other associated secondary causes are a complex and not fully understood process. These concepts can be elucidated through the studies of patients with malignancy. The development and application of methods that lead to more accurate diagnosis of the malignant phenomenon, and the search of the molecular mechanisms of malignancy are some important approaches that have led to progress in the last decade." - Anonymous Online Contributor

Unverified Answer

Has financial navigation proven to be more effective than a placebo?

"Financial navigation appears to result in faster and higher quality patient care. It has the potential for substantial cost savings. We propose that financial navigation be considered a standard mode of care in the management of cancer patients in a cost-effective manner." - Anonymous Online Contributor

Unverified Answer

Who should consider clinical trials for malignancies?

"Currently, the most commonly cited barrier to the participation in clinical research is time restriction, with only 25% of clinicians reporting they would not be able to conduct clinical trials due to a shortage of time. This barrier is not specific to patients with cancer; more than 40% of physicians and 45% of patients are willing to participate in clinical research even with a lack of time." - Anonymous Online Contributor

Unverified Answer

What does financial navigation usually treat?

"Financial navigation has had an increasing role in medical education in both the United States and Canada over the past few years. This has been associated with a corresponding increase in the number of resources available for patients with chronic conditions needing long-term medication management, disease monitoring, and assistance in making challenging medical decisions. It is the responsibility of medical schools and the financial navigation industry to devise a plan to integrate financial navigation into medical education. It is the responsibility of health care providers to offer patients a patient-friendly resource that enables patients to make healthcare decisions with confidence." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
See if you qualify for this trial
Get access to this novel treatment for Malignancies by sharing your contact details with the study coordinator.